This compound is a dimeric pyrrolobenzodiazepine (PBD) conjugate used as a payload in antibody-drug conjugate (ADC) manufacturing. It features a complex macrocyclic structure with multiple amide and ether linkages, and its high molecular weight and flexibility restrict conformer generation.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2057431-94-2
MC-VA-PAB-Exatecan
pharmaceutical raw material
Val-Ala-PABC-Exatecan
pharmaceutical raw material
MC-Val-Cit-PAB-MMAF
pharmaceutical raw material
Mafodotin
pharmaceutical raw material
Oxytetracycline hydrochloride
pharmaceutical raw material
D-asparagine
pharmaceutical raw material
Tenofovir monohydrate
pharmaceutical raw material
Pimozide
pharmaceutical raw material
(2S)-N-[(2S)-1-[4-[(6aS)-3-[3-[[(6aS)-2-methoxy-8-(4-methoxyphenyl)-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxy]propoxy]-2-methoxy-11-oxo-6a,7-dihydropyrrolo[2,1-c][1,4]benzodiazepin-8-yl]anilino]-1-oxopropan-2-yl]-2-amino-3-methylbutanamide
JBOVKCPZZZINSH-KWQGUWGISA-N
C[C@@H](C(=O)NC1=CC=C(C=C1)C2=CN3[C@@H](C2)C=NC4=CC(=C(C=C4C3=O)OC)OCCCOC5=C(C=C6C(=C5)N=C[C@@H]7CC(=CN7C6=O)C8=CC=C(C=C8)OC)OC)NC(=O)[C@H](C(C)C)N